![]() |
市場調查報告書
商品編碼
1904689
寵物處方糧市場預測至2032年:全球產品類型、寵物類型、成分、通路、應用、最終用戶和區域分析Pet Prescription Diets Market Forecasts to 2032 - Global Analysis By Product (Dry Food, Treats, Wet Food, Veterinary Diets and Other Products), Pet Type, Ingredient, Distribution Channel, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球寵物處方食品市場價值將達到 51.8 億美元,到 2032 年將達到 81.6 億美元,在預測期內的複合年成長率為 6.7%。
寵物處方糧是獸醫營養產品,由專家監督專門配製,旨在幫助管理伴侶動物的特定健康問題。這些處方糧基於臨床研究和營養科學研發,可解決消化系統疾病、腎臟疾病、肥胖、糖尿病、食物過敏和泌尿系統健康等問題。與一般寵物食品不同,處方糧的營養成分、特定食材和功能性添加劑均經過嚴格控制,有助於治療和復原。我們秉承傳統獸醫學和現代科學的理念,並專注於為寵物提供預防保健、治療支援和長期健康管理。
寵物慢性疾病呈上升趨勢
伴侶動物慢性疾病的持續成長是推動寵物處方糧市場發展的核心因素。隨著寵物壽命因照顧程度的提高和人類與動物之間情感紐帶的加深而延長,腎臟疾病、肥胖、糖尿病和胃腸道疾病等也變得越來越常見。獸醫越來越依賴經臨床驗證的營養干預措施作為第一線或輔助性治療。營養療法植根於多年的獸醫經驗,並藉助現代診斷技術進一步提升,使得處方營養成為寵物醫療保健中「必不可少」而非「可有可無」的組成部分。
處方飲食高成本
高成本是市場發展的一大限制因素,尤其是在價格敏感的地區。這些營養配方需要特殊的原料、嚴格的生產流程和廣泛的臨床檢驗,所有這些都導致了更高的價格。雖然傳統獸醫診所推崇治療性營養,但許多飼主面對持續的每月費用仍然猶豫不決。坦白說,經濟負擔往往決定了治療的持續性。如果沒有擴大保險覆蓋範圍或分級定價策略,成本障礙可能會阻礙其廣泛應用。
配方創新
配方創新為市場持續成長帶來了可喜的突破。營養科學的進步使得利用新型蛋白質、功能性纖維、益生菌和植物來源成分,可以研發出更精準、更具疾病特異性的配方。人們越來越關注偏好、消化率和潔淨標示配方,這些配方融合了現代科學技術,同時也體現了傳統的飼養理念。客製化、品種特異性配方以及兼具治療和預防功能的混合配方正變得越來越普遍。將成熟的獸醫學原理與前沿創新相結合的公司,將更有可能贏得持久的信任和市場佔有率。
監管和標籤方面的挑戰
監管和標籤的複雜性對市場穩定構成持續威脅。處方糧必須符合嚴格的獸醫、營養和安全標準,而這些標準因地區而異。標籤錯誤、前後矛盾的宣傳以及違反監管規定會迅速損害消費者信任,並導致處罰。隨著市場日趨成熟,監管機構正在加強監管,以保護動物健康。企業必須投資於透明的標籤、可靠的臨床證據以及對法規的嚴格遵守,才能生存和發展。反過來,這也構成了市場擴張的障礙。
新冠疫情對市場產生了複雜而深遠的影響。供應鏈中斷最初導致生產和分銷放緩,而獸醫就診限制則造成了診斷和飲食調整的延誤。然而,居家隔離令加強了寵物飼養和情感紐帶,促使飼主更加重視寵物的長期健康照護。電子商務和遠端獸醫諮詢服務蓬勃發展,重塑了分銷模式。回望過去,這場危機再次印證了「寵物是家人」這一長久以來的真理,同時也加速了現代通路的發展,這些管道將定義後疫情時代的成長。
預計在預測期內,蔬菜細分市場將佔據最大的市場佔有率。
由於其功能性和治療價值,預計蔬菜將在預測期內佔據最大的市場佔有率。蔬菜提供必需的膳食纖維、抗氧化劑和微量營養素,有助於消化健康、體重管理和代謝平衡。植物來源成分長期以來在獸醫營養領域備受信賴,如今正透過臨床研究不斷改進,以應對特定疾病。它們非常適合併融入腎臟病、糖尿病和胃腸道疾病的飲食方案中。隨著人們對清潔、天然和易消化成分的需求日益成長,蔬菜已穩固確立了其核心地位。
預計在預測期內,獸醫院板塊的複合年成長率將最高。
由於獸醫診所在診斷營養管理中發揮核心作用,預計在預測期內,獸醫診所板塊將實現最高的成長率。處方糧傳統上是在臨床環境中引入和使用的,而信任和專業權威至關重要。隨著診所採用整合診斷、治療和營養管理的護理模式,營養療法將成為常規程序。寵物保險的普及和預防性護理就診次數的增加將進一步推動成長。在一個信任至關重要的市場中,獸醫診所仍然是擴張的最強驅動力。
亞太地區預計將在整個預測期內佔據最大的市場佔有率,這主要得益於快速的都市化、不斷成長的可支配收入以及日益普及的寵物飼養率。中國、日本和印度等國家正經歷從基礎寵物餵食到以醫療為指導的營養管理的轉變。人們對獸醫建議的傳統信任以及日益增強的預防保健意識正在推動這一轉變。隨著當地企業與全球品牌合作,該地區正將傳統的關懷理念與現代營養科學結合,從而鞏固主導地位。
在預測期內,北美地區預計將實現最高的複合年成長率,這主要得益於其先進的獸醫基礎設施和高昂的寵物醫療保健支出。該地區的寵物飼主願意將處方糧作為疾病管理和預防保健的一部分。健全的法規結構、普及的寵物保險以及對創新技術的早期應用也是推動成長的因素。北美地區根深蒂固的務實概念認為,如果營養能改善生活品質,那麼投入的資金就是值得的。這種理念,加上持續的產品創新,正助力北美市場維持快速成長。
According to Stratistics MRC, the Global Pet Prescription Diets Market is accounted for $5.18 billion in 2025 and is expected to reach $8.16 billion by 2032 growing at a CAGR of 6.7% during the forecast period. Pet Prescription Diets are specially formulated veterinary nutrition products designed to support the management of specific medical conditions in companion animals under professional supervision. Developed using clinical research and nutritional science, these diets address issues such as digestive disorders, kidney disease, obesity, diabetes, food allergies, and urinary health. Unlike standard pet foods, prescription diets contain carefully controlled nutrient profiles, targeted ingredients, and functional additives to aid treatment and recovery. Rooted in traditional veterinary practice and modern science, they emphasize preventive care, therapeutic support, and long-term health management for pets.
Growing Prevalence of Chronic Pet Diseases
The steady rise in chronic conditions among companion animals is a central force pushing the pet prescription diets market forward. As pets live longer due to better care and closer human-animal bonds ailments such as kidney disease, obesity, diabetes, and gastrointestinal disorders have become more common. Veterinarians increasingly rely on clinically proven nutritional interventions as first-line or supportive therapy. Rooted in long-standing veterinary wisdom, diet-based management is now reinforced by modern diagnostics, making prescription nutrition an essential, not optional, component of pet healthcare.
High Cost of Prescription Diets
High costs remain a stubborn restraint in the market, particularly in price-sensitive regions. These diets demand specialized ingredients, controlled manufacturing processes, and extensive clinical validation, all of which drive up prices. While traditional veterinary practice supports therapeutic feeding, many pet owners still hesitate when faced with recurring monthly expenses. The reality is blunt affordability often dictates compliance. Without broader insurance coverage or tiered pricing strategies, cost barriers may limit adoption.
Innovation in Formulations
Innovation in formulations presents a promising opening for sustained market growth. Advances in nutritional science are enabling more precise, condition-specific diets using novel proteins, functional fibers, probiotics, and plant-based ingredients. There is growing emphasis on palatability, digestibility, and clean-label formulations that echo traditional feeding values while embracing modern science. Customization, breed-specific diets, and hybrid therapeutic-preventive formulations are gaining ground. Companies that balance time-tested veterinary principles with forward looking innovation stand to earn lasting trust and market share.
Regulatory & Labeling Challenges
Regulatory and labeling complexities pose a persistent threat to market stability. Prescription diets must meet stringent veterinary, nutritional, and safety standards that vary across regions. Mislabeling, inconsistent claims, or regulatory non-compliance can quickly erode credibility and invite penalties. As markets mature, authorities are tightening oversight to protect animal health. Companies must invest in transparent labeling, robust clinical backing, and regulatory diligence to survive and scale. Thus, it hinders market expansion.
The COVID-19 pandemic left a mixed but lasting imprint on the market. Supply chain disruptions initially slowed production and distribution, while restricted veterinary visits delayed diagnoses and diet transitions. Yet confinement also strengthened pet ownership and emotional attachment, pushing owners to prioritize long-term health. E-commerce and tele-veterinary consultations gained traction, reshaping distribution models. In hindsight, the crisis reinforced a traditional truth pets are family while accelerating modern channels that now define post-pandemic growth.
The vegetables segment is expected to be the largest during the forecast period
The vegetables segment is expected to account for the largest market share during the forecast period, due to its functional and therapeutic value. Vegetables provide essential fibers, antioxidants, and micronutrients that support digestive health, weight management, and metabolic balance. Long trusted in veterinary nutrition, plant-based components are now refined through clinical research to target specific conditions. Their compatibility with renal, diabetic, and gastrointestinal diets makes them indispensable. As demand rises for clean, natural, and easily digestible ingredients, vegetables hold firm at the core.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate, due to their central role in diagnosis-driven nutrition. Prescription diets are traditionally introduced and monitored within clinical settings, where trust and professional authority matter most. As clinics adopt integrated care models-combining diagnostics, treatment, and nutrition dietary therapy becomes routine. Rising pet insurance coverage and preventive care visits further support growth. In a market where credibility is currency, veterinary clinics remain the strongest engine of expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rapid urbanization, rising disposable incomes, and expanding pet ownership. Countries such as China, Japan, and India are witnessing a shift from basic pet feeding to medically guided nutrition. Traditional respect for veterinary advice, combined with growing awareness of preventive healthcare, supports adoption. As local players partner with global brands, the region blends long-standing care values with modern nutritional science, anchoring its market leadership.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced veterinary infrastructure and high pet healthcare spending. Pet owners in the region readily accept prescription diets as part of disease management and preventive care. Strong regulatory frameworks, widespread pet insurance, and early adoption of innovation fuel growth. The culture is frank and practical if nutrition improves quality of life, it's worth the cost. This mindset, paired with continuous product innovation, keeps North America on a fast upward track.
Key players in the market
Some of the key players in Pet Prescription Diets Market include Hill's Pet Nutrition, WellPet LLC, Royal Canin, Arden Grange, Purina Pro Plan Veterinary Diets, Kemin Industries, Iams Veterinary Formulas, Elanco Animal Health, Eukanuba Veterinary Diets, Zoetis Inc., Farmina Pet Foods, Spectrum Brands Holdings, Virbac, Blue Buffalo Natural Veterinary Diet and Dechra Pharmaceuticals.
In June 2025, Zoetis has signed a strategic consulting deal with global IT firm Infosys to boost its digital capabilities and IT operations. Under the long-term engagement, Infosys will integrate advanced AI and automation solutions to enhance agility, improve operational efficiency, and better support veterinarians, livestock producers, and pet owners worldwide.
In December 2025, Zoetis and Colorado State University's AgNext have launched a strategic cattle research collaboration to deepen scientific understanding of sustainable livestock production. The partnership will gather baseline data on greenhouse gas emissions and conduct lifecycle assessments to inform better animal health, in response to evolving sustainability goals.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.